OncoSec Medical Inc. , a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will present at four events in June. The company’s agenda includes a number of high-profile scientific and investment conferences, coming on the heels of their presentation of new clinical data at the 2014 ASCO Annual Meeting.
from Content Keyword RSS http://ift.tt/1kH0uGc
via IFTTT
from Content Keyword RSS http://ift.tt/1kH0uGc
via IFTTT
No comments:
Post a Comment